|
|
 |
| |
|
Home > Drug Companies > Endo Pharmaceuticals, Inc.
Endo Pharmaceuticals, Inc.
Endo became Endo Pharmaceuticals Inc. as a result of a management buyout from DuPont Merck in 1997. They are a specialty pharmaceutical company engaged in the research, development, sale and marketing of prescription pharmaceuticals used primarily to treat and manage pain.
They are a specialty pharmaceutical company with market leadership in pain management. They are engaged in the research, development, sale and marketing of branded and generic prescription pharmaceuticals used primarily to treat and manage pain. According to IMS Health data, the total U.S. market for pain management pharmaceuticals, excluding over the counter products, totaled 18.9 billion dollar in 2004. This represents an approximately 16 percent compounded annual growth rate since 2000.
They have a portfolio of branded, marketed products that includes established brand names such as Lidoderm lidocaine patch 5 percent, Percocet oxycodone and acetaminophen tablets USP CII, and Percodan oxycodone and aspirin tablets, USP CII, as well as newer products Frova frovatriptan succinate tablets and DepoDur morphine sulfate extended-release liposome injection. Branded products comprised approximately two-thirds of their net sales in 2004. Their generic portfolio, which accounted for about one-third of net sales in 2004, consists of products that cover a variety of indications, most of which are focused in pain management. They focus on generics that have one or more barriers to market entry, such as complex formulation, regulatory or legal challenges or difficulty in raw material sourcing.
They have established research and development expertise in analgesics and devote significant resources to this effort so that they can maintain and develop their product pipeline. Their late-stage branded product pipeline includes two filed NDAs and six products in Phase III or Phase II clinical trials.
Through an internal sales force of approximately 370 sales representatives in the United States, they market their branded pharmaceutical products to high-prescribing physicians in pain management, surgery, oncology, anesthesiology and primary care. Their sales force also targets retail pharmacies and other healthcare professionals throughout the United States.
Back to Drug Companies
|
|
|
|
|
|
|
|